Added to YB: 2025-12-16
Pitch date: 2025-12-12
TEVA [bullish]
Teva Pharmaceutical Industries Limited
+0.86%
current return
Author Info
Kontra Investment Xchange is trying to build wealth by investing in good companies and letting those investments compound over many years. Sign up for the newsletter.
Company Info
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
Market Cap
$34.2B
Pitch Price
$95.88
Price Target
35.00 (-64%)
Dividend
N/A
EV/EBITDA
10.35
P/E
48.27
EV/Sales
2.92
Sector
Pharmaceuticals
Category
turnaround
Teva’s ($TEVA) 'Pivot to Growth': Moving from fiction to nonfiction
TEVA: 'Pivot to Growth' strategy validated with Olanzapine NDA submission Dec 2025 targeting $1.5-2B uncontested schizophrenia market. Gross margins expanding from 48% (Q1 '23) to 57-58% target by 2027. Pipeline: Austedo $3B+ peak, Duvakitug $5B potential (Sanofi partner). Wall Street re-rating: BofA $32 PT, Barclays $35 PT.
Read full article (4 min)